Protect Pharmaceutical Corporation
PRTT
$0.18
-$0.03-15.29%
OTC PK
| 06/30/2018 | 03/31/2018 | 12/31/2017 | 09/30/2017 | 06/30/2017 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 700.00 | -- | 0.00 | -- | 100.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 700.00 | -- | 0.00 | -- | 100.00K |
| Operating Income | -700.00 | -- | 0.00 | -- | -100.00K |
| Income Before Tax | -4.40K | -3.70K | -3.90K | -3.00K | -100.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.40K | -3.70K | -3.90K | -3.00K | -100.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.40K | -3.70K | -3.90K | -3.00K | -100.30K |
| EBIT | -700.00 | -- | 0.00 | -- | -100.00K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | -0.09 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.06 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -0.09 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.06 |
| Average Basic Shares Outstanding | 1.11M | 1.11M | 1.11M | 1.11M | 1.11M |
| Average Diluted Shares Outstanding | 1.11M | 1.36M | 1.11M | 1.23M | 1.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |